Status:
COMPLETED
Vitamin D Supplementation to Patients With Type 2 Diabetes
Lead Sponsor:
University of Tromso
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
21-75 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to evaluate if supplementation with vitamin D in a dose of 40.000 IU per week will result in improved metabolic control in patients with type 2 diabetes.
Detailed Description
The purpose of the study is to evaluate if supplementation with vitamin D in a dose of 40.000 IU per week will result in improved metabolic control in patients with type 2 diabetes. We will include 7...
Eligibility Criteria
Inclusion
- Type 2 diabetes for at least 1 year
- age 21-75 years
- long-acting insulin at bedtime
- metformin during the day
- for women of child bearing age use of reliable method of birth control
Exclusion
- serum creatinine above 130 umol/l for men and above 110 for women
- systolic blood pressure \> 175 or diastolic \> 104 mmHg
- heart disease
- serum calcium \> 2.54 mmol/l
- history of renal stones
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00400491
Start Date
June 1 2006
End Date
September 1 2007
Last Update
May 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Unit, University Hospital of North Norway
Tromsø, Tromsø, Norway, 9038